I've posted on RVX about China's aggressive buying of foreign companies in key strategic industries. Li Shufu of Geely Group (China's largest private auto maker) has just purchased 9.7% of Daimler AG. The Liberal gov't in Canada is finally waking up to Chinese acquisitions of key strategy industries when they blocked the sale of Bombardier's C Series jet to a Chinese entity because this plane has the most advanced avionics in commercial jets and it is the most fuel efficient. The Liberals set up a marriage between Bombardier and Airbus for 50.1% of the C Series jet rather than giving the Chinese the advantage. The sale of Canada' largest construction company Aecon to China Construction Group (CCCC) is being challenged because Aecon is involved in strategic infrastructure projects and refurbishing neuclear plants. In 2017 ITF Technologies (fiber optics) was bought by O-Net of Hong Kong. In 2017 Hytera Communications Corp of China took over high-tech firm Norstat of Vancouver. This rankled the U.S. Defense Department because Norstat has contracts with them. And the list goes on. China graduates 1,000,000 IP lawyers each year according to Jim Balsillie, former Co-CEO of Blackberry/Research in Motion.

Trump has woken up. Unfortunately our Mr Trudeau, probably heavily influenced by Dominic Barton (a Canadian who is the top dog at McKinnsey & Co globally) is blindly following the goal of Canada's need for foreign direct investment no matter what the country or industry.

My point is that China lead by Xi Jinping is a strategic country that wants to catapult itself to being the largest economy in the world and one strategy is buying IP and the technology that goes with it. They do not just want to remain a commodity economy. They want to dominate the intellectual/value added economic sphere.

Opinion/Hypothesis (not facts) - So what is the point in my "pointless" rambling. My point is that if Hepalink and RVX are viewed as important and inexpensive entries into the potential leading edge and possible breahthrough science and medicine of epigenetics then it fits within the broader Chinese strategy and thus may well be funded by Chinese gov't banks.

To my knowledge Hepalink does not own any shares in Zenith yet. Might this be a source for the $10 million private placement? (FYI - Eastern owns 38.6%).

On the RVX side the fact that Hepa came to the rescue with $87 million to retire the debt and now owns 43% of RVX plus their $8M FROR for the USA tells me Hepa is hungry for this (just an opinion). If Don can't get the next round of financing Hepa may get a real bargan and I do not think our gov't would block the sale. 

I do recall that Zenith has a USA registration.

GLTA

rambling Toinv     :)